FORENSIC DRUG-TESTING FOR OPIATES .5. URINE TESTING FOR HEROIN, MORPHINE, AND CODEINE WITH COMMERCIAL OPIATE IMMUNOASSAYS

被引:26
作者
CONE, EJ
DICKERSON, S
PAUL, BD
MITCHELL, JM
机构
[1] USN,DRUG SCREENING LAB,NORFOLK,VA 23511
[2] USN,DRUG SCREENING LAB,JACKSONVILLE,FL 32212
关键词
D O I
10.1093/jat/17.3.156
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Urine specimens collected after heroin, morphine, and codeine administration were tested by four commercial opiate immunoaasays (TDx, CAC, ABUS, and EMIT) and by GC/MS. Quantitative immunoassay results (morphine equivalents) were compared with results by GC/MS for total morphine, free morphine, or total codeine. Mean detection times for the broadly cross-reacting immunoassays (TDx, ABUS, and EMIT, 300 ng/mL cutoff) ranged from 15–44 hours following heroin and morphine administration and 33–54 hours following codeine administration. Detection times obtained with CAC (25 ng/mL cutoff) tended to be somewhat shorter as a result of the high selectivity of the antibody for free morphine. High correlations over a wide concentration range were obtained for TDx, CAC, and ABUS versus GC/MS, with specimens collected after heroin and morphine administration. EMIT showed a high correlation over a narrow concentration range (0–1000 ng/mL) with heroin and morphine specimens, but responses plateaued at higher concentrations. There was substantial variability in immunoassay responses with specimens collected after codeine administration. Generally, this study demonstrated that immunoassay responses for opiate urine testing can be used as a semi-quantitative guide for GC/MS confirmation; however, the presence of codeine increased variability and diminished the accuracy of the immunoassay response. © 1993 Oxford University Press.
引用
收藏
页码:156 / 164
页数:9
相关论文
共 12 条
[1]  
AZIZ K, 1990, CLIN LAB MED, V10, P493
[2]  
CATLIN DH, 1973, AM J CLIN PATHOL, V60, P719
[3]  
CONE EJ, 1991, J ANAL TOXICOL, V15, P1
[4]   FORENSIC DRUG-TESTING FOR OPIATES .4. ANALYTICAL SENSITIVITY, SPECIFICITY, AND ACCURACY OF COMMERCIAL URINE OPIATE IMMUNOASSAYS [J].
CONE, EJ ;
DICKERSON, S ;
PAUL, BD ;
MITCHELL, JM .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1992, 16 (02) :72-78
[5]   FORENSIC DRUG-TESTING FOR OPIATES .3. URINARY-EXCRETION RATES OF MORPHINE AND CODEINE FOLLOWING CODEINE ADMINISTRATION [J].
CONE, EJ ;
WELCH, P ;
PAUL, BD ;
MITCHELL, JM .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1991, 15 (04) :161-166
[6]   VALIDITY TESTING OF THE TDX COCAINE METABOLITE ASSAY WITH HUMAN SPECIMENS OBTAINED AFTER INTRAVENOUS COCAINE ADMINISTRATION [J].
CONE, EJ ;
MENCHEN, SL ;
MITCHELL, J .
FORENSIC SCIENCE INTERNATIONAL, 1988, 37 (04) :265-275
[7]  
Gorodetzky CW, 1977, HDB EXPT PHARM, V45, P319
[8]  
LEMBERGER L, 1976, PHARM MARIHUANA, V1, P125
[9]   FORENSIC DRUG-TESTING FOR OPIATES .2. METABOLISM AND EXCRETION RATE OF MORPHINE IN HUMANS AFTER MORPHINE ADMINISTRATION [J].
MITCHELL, JM ;
PAUL, BD ;
WELCH, P ;
CONE, EJ .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1991, 15 (02) :49-53
[10]   SIMULTANEOUS IDENTIFICATION AND QUANTITATION OF CODEINE AND MORPHINE IN URINE BY CAPILLARY GAS-CHROMATOGRAPHY AND MASS-SPECTROSCOPY [J].
PAUL, BD ;
MELL, LD ;
MITCHELL, JM ;
IRVING, J ;
NOVAK, AJ .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1985, 9 (05) :222-226